CID 134611548

Lorpucitinib

Structural Information

Molecular Formula
C22H28N6O2
SMILES
CC(C)(CNC(=O)CC1=NC2=CN=C3C(=C2N1C4CCC(CC4)CC#N)C=CN3)O
InChI
InChI=1S/C22H28N6O2/c1-22(2,30)13-26-19(29)11-18-27-17-12-25-21-16(8-10-24-21)20(17)28(18)15-5-3-14(4-6-15)7-9-23/h8,10,12,14-15,30H,3-7,11,13H2,1-2H3,(H,24,25)(H,26,29)
InChIKey
NJKMSBSVJSQUBU-UHFFFAOYSA-N
Compound name
2-[3-[4-(cyanomethyl)cyclohexyl]-3,5,8,10-tetrazatricyclo[7.3.0.02,6]dodeca-1,4,6,8,11-pentaen-4-yl]-N-(2-hydroxy-2-methylpropyl)acetamide
Related CIDs

2D Structure

compound 2d structure
2
Annotation Hits

1
References

67
Patents

408.2274 Da
Monoisotopic Mass

1.1
XlogP (predicted)

Profile

Predicted Collision Cross Section

Adduct m/z Predicted CCS (Ų)
[M+H]+ 409.23468 200.6
[M+Na]+ 431.21662 209.7
[M+NH4]+ 426.26122 201.9
[M+K]+ 447.19056 204.5
[M-H]- 407.22012 193.5
[M+Na-2H]- 429.20207 200.1
[M]+ 408.22685 198.8
[M]- 408.22795 198.8
m/z: mass to charge ratio of the adduct.
Predicted Collision Cross Section (CCS) values (Ų) per adduct calculated using CCSbase.

Literature stripe

literature stripe

Patent stripe

patents stripe